Go Beyond the Boundaries of Status-Quo.
Break Through To More Breakthroughs.
Phlowʼs U.S.-based, next-gen CDMO provides R&D services for APIs and Key Starting Materials and streamlines supply, reduces exorbitant costs, and creates unparalleled quality.
1. “Review of the Food and Drug Administration’s Foreign Drug Inspection Process.” U.S. HHS Office of Inspector General, 2022.
Collaborate with Phlow.
Pioneering life-changing medicines all begins with a conversation. Let’s connect and make the unbelievable happen.